Mmastodon BusinessMarkets first seen 11 h ago, last 51 min ago, peak #1

Kobayashi Pharmaceutical weighs takeover offer above ¥500 billion

Original: Kobayashi Pharmaceutical, the firm that was at the center of a supplement contamination scandal involving suspected deat

Kobayashi Pharmaceutical, the Japanese company at the center of a supplement contamination scandal linked to suspected deaths, is reportedly considering a buyout offer worth more than ¥500 billion. The news has drawn attention given the company's damaged reputation and the uncertain future of its consumer health business following the red yeast rice supplement scandal.

Why now: Reports of a major buyout offer for a scandal-hit company have reignited interest in the fallout from the supplement contamination case.

Kobayashi Pharmaceutical

Open on mastodon →

Evidence

• Kobayashi Pharmaceutical, the firm that was at the center of a supplement contamination scandal involving suspected deaths, is said to be considering a potential buyout offer of more than ¥500 billion. https://www. japantimes.co.jp/business/2026… · thejapantimes · 4

API: https://socialmediatrends-api.osmike.com/v1/trends/18193